Correlation Between Evoke Pharma and Omeros
Can any of the company-specific risk be diversified away by investing in both Evoke Pharma and Omeros at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evoke Pharma and Omeros into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evoke Pharma and Omeros, you can compare the effects of market volatilities on Evoke Pharma and Omeros and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evoke Pharma with a short position of Omeros. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evoke Pharma and Omeros.
Diversification Opportunities for Evoke Pharma and Omeros
-0.69 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Evoke and Omeros is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Evoke Pharma and Omeros in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Omeros and Evoke Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evoke Pharma are associated (or correlated) with Omeros. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Omeros has no effect on the direction of Evoke Pharma i.e., Evoke Pharma and Omeros go up and down completely randomly.
Pair Corralation between Evoke Pharma and Omeros
Given the investment horizon of 90 days Evoke Pharma is expected to generate 0.6 times more return on investment than Omeros. However, Evoke Pharma is 1.67 times less risky than Omeros. It trades about 0.07 of its potential returns per unit of risk. Omeros is currently generating about 0.0 per unit of risk. If you would invest 427.00 in Evoke Pharma on October 10, 2024 and sell it today you would earn a total of 25.00 from holding Evoke Pharma or generate 5.85% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Evoke Pharma vs. Omeros
Performance |
Timeline |
Evoke Pharma |
Omeros |
Evoke Pharma and Omeros Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Evoke Pharma and Omeros
The main advantage of trading using opposite Evoke Pharma and Omeros positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evoke Pharma position performs unexpectedly, Omeros can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Omeros will offset losses from the drop in Omeros' long position.Evoke Pharma vs. Petros Pharmaceuticals | Evoke Pharma vs. Cumberland Pharmaceuticals | Evoke Pharma vs. Painreform | Evoke Pharma vs. Aquestive Therapeutics |
Omeros vs. Crinetics Pharmaceuticals | Omeros vs. Enanta Pharmaceuticals | Omeros vs. Amicus Therapeutics | Omeros vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |